iHub My Stocks Activity
Ticker Buzz Cloud
Most Followed Members
Top PlusOneCoin Posters
Data Tools >
Price & News Alerts
Markets in 3D
More Tools >
My Image Gallery
Personal Finance Q&A
PLUS1 Info & Faucet
Mining Profit Calculator
Wuhan General Group Inc. ( MJ MedTech) (WUHN)
Add WUHN Price Alert
Search This Board:
1/15/2019 5:17:21 AM
- Board type:
- Posts Today:
WUHAN BLOWER CO., LTD
Heavy Electrical Equipment
Wuhan General Group (China) Co., Ltd. is a China-based holding company. The Company operates through its subsidiaries, Wuhan Blower Co., Ltd., which is engaged in energy generation in the field; Wuhan Generating Equipment Co., Ltd.; Wuhan Xin Green Environmental Protection Equipment Manufacturing Co., Ltd., which is focused on numerical control machine tools, fans and power plant auxiliary products in the field of manufacturing. The Company, through its subsidiaries, also manufactures fans and power generation equipment, and power plant auxiliary products. The Company is also a supplier of CNC machine tool equipment. Its focus is on equipment manufacturing, environmental protection and new energy fields.
THE COMPANY BECAME A SHELL IN 2013
In 2017, New Management took control of the shell and spent money and effort during 2018 to clean up the shell.
They have settled and paid off all past debts with the State of Nevada and the Transfer Agent.
They brought the company back to
status and plan to up list to OTCQB
Also, they have renewed OTCIQ service and Nevada State licence for a full year.
reduced the outstanding common shares
count to 39.7M shares from 100M.
No toxic notes
have been issued and management have been following their promises.
Changed SIC - Industry Classification to
Medicinal and botanicals
Interim CEO, President
Dr. Anna Morera Leralta
Jeff Robison (on the right)
New upcoming CEO
Note that he is having breakfast with Matthew Bucklin ( on the left), husband of Ariana
How Rich Is the Rockefeller Family Today? The value of Rockefeller's fortune at its peak, in today's dollars, at $318.3 billion in Sep 1, 2016
Wuhan General Group is an alternative medicinal and botanicals company focused on the application of emerging technologies as well as the clinical research and health application of cannabidiol (CBD)-based medicine to the human and pet care industry for cancer, cardiovascular, mental disorders, chronic pain, and others in Canada, the United States, Europe, and Australia. We are committed to supplying medical grade CBD products, superior patient care while increasing shareholders ROI. We're on track to achieve a positive cash flow in the first quarter of 2019. According to a new estimate from cannabis industry analysts the Brightfield Group, the CBD market alone could hit $22 billion by 2022.
Press Release | 12/19/2018
Wuhan Provides Update on Its Entry into The Cannabis Market
Press Release | 11/19/2018
Wuhan Provides MJ MedTech Acquisition Update
Press Release | 10/09/2018
Medical Marijuana Company Acquisition: Wuhan Strengthens International Entry in the Marijuana Market
Press Release | 10/04/2018
ePlay and Wuhan Announce Strategic Partnership to Create New Medical Cannabis App
Press Release | 10/04/2018
Wuhan Signs Letter of Intent to Acquire MJ MedTech
Press Release | 09/18/2018
Wuhan Announces Appointment of Chief Medical Officer
Press Release | 09/14/2018
Wuhan General Group confirms the cancelation of 60% of its outstanding common shares